id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0090-0276,FDA,FDA-2011-N-0090,Unique Device Identification System; Editorial Provisions; Technical  Amendment,Rule,Final Rule,2016-03-04T05:00:00Z,2016,3,2016-03-04T05:00:00Z,,2016-03-04T14:50:28Z,2016-04707,0,0,0900006481ea0935
FDA-2011-N-0090-0275,FDA,FDA-2011-N-0090,FDA/OC to Dockets Management - Memorandum,Other,Memorandum,2013-10-24T04:00:00Z,2013,10,2013-10-24T04:00:00Z,,2013-10-24T15:45:52Z,,0,0,090000648145cdfb
FDA-2011-N-0090-0274,FDA,FDA-2011-N-0090,Unique Device Identification System,Rule,Final Rule,2013-09-24T04:00:00Z,2013,9,2013-09-24T04:00:00Z,,2013-09-26T13:15:30Z,2013-23059,0,0,09000064814340dc
FDA-2011-N-0090-0273,FDA,FDA-2011-N-0090,Alphatec Spine - Supplement,Supporting & Related Material,Supplement,2013-02-01T05:00:00Z,2013,2,,,2013-02-01T20:18:14Z,,0,0,09000064811df0d0
FDA-2011-N-0090-0222,FDA,FDA-2011-N-0090,Unique Device Identification System; Amendment,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-11-19T05:00:00Z,2012,11,2012-11-19T05:00:00Z,2012-12-20T04:59:59Z,2012-12-20T03:02:20Z,2012-28015,0,0,090000648116ca95
FDA-2011-N-0090-0218,FDA,FDA-2011-N-0090,GS1 US - Comment,Supporting & Related Material,,2012-11-16T00:00:00Z,2012,11,,,2012-11-27T21:01:51Z,,0,1,09000064811626df
FDA-2011-N-0090-0219,FDA,FDA-2011-N-0090,GS1 US - Comment,Supporting & Related Material,,2012-11-16T00:00:00Z,2012,11,,,2012-11-27T21:02:35Z,,0,1,09000064811626e2
FDA-2011-N-0090-0220,FDA,FDA-2011-N-0090,GS1 US - Comment,Supporting & Related Material,,2012-11-16T00:00:00Z,2012,11,,,2012-11-27T21:03:24Z,,0,1,09000064811626e4
FDA-2011-N-0090-0107,FDA,FDA-2011-N-0090,GS1® and the GS1 US™ - Supplement re FDA-2011-N-0090-0080,Other,Supplemental Comment,2012-11-07T05:00:00Z,2012,11,2012-07-10T04:00:00Z,2012-11-08T04:59:59Z,2012-11-28T17:01:09Z,,0,0,090000648115ee5a
FDA-2011-N-0090-0022,FDA,FDA-2011-N-0090,National Council for Prescription Drug Programs (NCPDP) to FDA\CDRH -  Letter,Other,Letter(s),2012-09-19T04:00:00Z,2012,9,2012-09-19T04:00:00Z,,2012-11-19T14:25:58Z,,0,0,09000064810871a6
FDA-2011-N-0090-0023,FDA,FDA-2011-N-0090,Advancing Patient Safety Coalition to Office of Management and Budget  -  Letter,Other,Letter(s),2012-09-19T04:00:00Z,2012,9,2012-09-19T04:00:00Z,,2012-11-19T14:22:30Z,,0,0,090000648108723e
FDA-2011-N-0090-0019,FDA,FDA-2011-N-0090,Agency Information Collection Activities; Proposed Collection; Unique Device Identification System; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2012-09-17T04:00:00Z,2012,9,2012-09-17T04:00:00Z,2012-10-26T03:59:59Z,2012-11-21T03:02:41Z,2012-22821,0,0,09000064811196ad
FDA-2011-N-0090-0002,FDA,FDA-2011-N-0090,"Unique Device Identification System - OMB Review, Executive Order 12866  July 10,2012 - Reference",Other,References (internal) (REF),2012-07-19T04:00:00Z,2012,7,2012-07-19T04:00:00Z,,2012-07-19T12:02:47Z,,0,0,09000064810a3278
FDA-2011-N-0090-0001,FDA,FDA-2011-N-0090,Unique Device Identification System,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-07-10T04:00:00Z,2012,7,2012-07-10T04:00:00Z,2012-11-08T04:59:59Z,2012-12-18T03:02:50Z,2012-16621,0,0,0900006481082634